Liver as a target of human immunodeficiency virus infection

World J Gastroenterol. 2018 Nov 14;24(42):4728-4737. doi: 10.3748/wjg.v24.i42.4728.

Abstract

Liver injury is a characteristic feature of human immunodeficiency virus (HIV) infection, which is the second most common cause of mortality in HIV-infected patients. Now it is recognized that liver plays a key role in HIV infection pathogenesis. Antiretroviral therapy (ART), which suppresses HIV infection in permissive immune cells, is less effective in hepatocytes, thereby making these cells a silent reservoir of HIV infection. In addition to direct hepatotoxic effects of HIV, certain ART treatment modalities provide hepatotoxic effects. The exact mechanisms of HIV-triggered chronic hepatitis progression are not elucidated, but the liver is adversely affected by HIV-infection and liver cells are prominently involved in HIV-elicited injury. These effects are potentiated by second hits like alcohol. Here, we will focus on the incidence of HIV, clinical evidence of HIV-related liver damage, interactions between HIV and liver cells and the role of alcohol and co-infection with hepatotropic viruses in liver inflammation and fibrosis progression.

Keywords: Alcohol; Antiretroviral therapy; Apoptosis; Fibrosis; Immunodeficiency virus; Inflammation; Liver cells.

Publication types

  • Review

MeSH terms

  • Alcohol Drinking / adverse effects
  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Chemical and Drug Induced Liver Injury / epidemiology
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / pathology
  • Coinfection / epidemiology
  • Coinfection / virology
  • Disease Progression
  • HIV / drug effects
  • HIV / isolation & purification
  • HIV / pathogenicity*
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology
  • HIV Infections / virology
  • Hepacivirus / isolation & purification
  • Hepacivirus / pathogenicity
  • Hepatitis B / epidemiology
  • Hepatitis B / pathology
  • Hepatitis B / virology
  • Hepatitis B virus / pathogenicity
  • Hepatitis C / epidemiology
  • Hepatitis C / pathology
  • Hepatitis C / virology
  • Hepatocytes / drug effects
  • Hepatocytes / pathology
  • Hepatocytes / virology
  • Humans
  • Incidence
  • Liver / cytology
  • Liver / drug effects
  • Liver / pathology
  • Liver / virology
  • Liver Cirrhosis / epidemiology
  • Liver Cirrhosis / pathology
  • Liver Cirrhosis / virology*

Substances

  • Anti-HIV Agents